secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-10-02T11:30:19+00:00
Accession:  0001193125-26-411259
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Cerenome files Sept 30 investor deck; exhibit has no financials, pipeline data or guidance
--------------------------------------------------------------------------------

- Investor presentation dated September 30, 2026 was filed as Exhibit 99.1, but the appended text contains only a title page ('Corporate Presentation (NASDAQ:CNSY)') with no numbers or outlook.
- No earnings, revenue, cash balance, trial data or guidance is disclosed anywhere in the 8-K or its exhibit, so no investment conclusions can be drawn from this filing.
- Registrant is Cerenome, Inc., formerly Plus Therapeutics, Inc., with common stock on the Nasdaq Capital Market under symbol CNSY and offices at 6420 Levit Green Boulevard, Suite 310, Houston, Texas.
- Report signed October 2, 2026 by President and Chief Executive Officer Marc H. Hedrick, M.D.; Item 8.01 lists only the presentation update as the event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526411259/0001193125-26-411259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526411259/cnsy-20261002.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-411259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer